COVID-19: New COBREVAX vaccine could help immunize low-income countries
CA, 18 Jan 2022
Poorer nations are still struggling to fully immunize people against COVID-19, as they grapple with expensive vaccine patents and complex production.
According to the scientific publication Our World in Data, as of Jan. 14, nearly 78 per cent of Canada's entire population has already been fully vaccinated – yet in Nigeria, only 2.3 per cent of the African country's people are fully immunized.
Jackson Proskow explains how Texas researchers are trying to make sure no one gets left behind with a groundbreaking new vaccine called COBREVAX, and without a huge price tag.
For more info, please go to https://globalnews.ca/news/8506238/covid-vaccine-low-income-countries-corbevax/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Coronavirus #COVID19 #GlobalNews
According to the scientific publication Our World in Data, as of Jan. 14, nearly 78 per cent of Canada's entire population has already been fully vaccinated – yet in Nigeria, only 2.3 per cent of the African country's people are fully immunized.
Jackson Proskow explains how Texas researchers are trying to make sure no one gets left behind with a groundbreaking new vaccine called COBREVAX, and without a huge price tag.
For more info, please go to https://globalnews.ca/news/8506238/covid-vaccine-low-income-countries-corbevax/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Coronavirus #COVID19 #GlobalNews
